Physician profile
Michael J Lee
NPI 1881896652
$107,221.82
in general payments reported to CMS, 2019-2025
12 companies · $7,639 in 2025
The $7,639 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43K · 2020: $4,577 · 2021: $17K · 2022: $16K · 2023: $13K · 2024: $5,650 · 2025: $7,639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,661 · Consulting Fee: $7,048 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,500 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,600 · Food and Beverage: $2,757.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,661.33 |
| Consulting Fee | $7,047.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,600.00 |
| Food and Beverage | $2,756.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $37,873.47 | 2019-2024 | Sable, Excelsiusgps Robotic Navigation System, Excelsius3d Imaging System |
| Stryker Corporation | $29,129.48 | 2019-2025 | Mako |
| Synthes Gmbh | $20,352.68 | 2021-2025 | |
| Medical Device Business Services, INC. | $15,235.38 | 2019-2025 | Velys |
| Medtronic, INC. | $3,633.97 | 2023-2025 | Mazor X System, Stealthstation S8 Platform, Micra |
| Revance Therapeutics, INC. | $429.94 | 2024-2025 | Daxxify |
| Depuy Synthes Sales INC. | $209.89 | 2024-2025 | Velys, Sentio, Teligen |
| Augmedics INC. | $201.25 | 2024 | Xvision |
| Sanara Medtech INC. | $95.47 | 2023 | Celleraterx |
| Glaxosmithkline, LLC. | $22.59 | 2023 | Zejula |
| Djo, LLC | $20.24 | 2023 | Cmf |
| Heron Therapeutics, INC. | $17.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.